Men with genes that increase the risk of prostate cancer should have annual checks from the age of 40, research has shown.

By targeting a newly uncovered weakness in prostate cancer cells, this could offer an improved treatment for the disease.

Drugs already in use could be combined to form a two-pronged attack on advanced prostate cancer, a study suggests.

Scientists have identified a novel two-pronged treatment method, offering significant potential for patients battling ...

A double-pronged attack on advanced prostate cancer could help treat as many as two in five patients with late-stage disease, ...

A targeted cancer drug niraparib, used in combination with hormone therapy, was found to reduce the risk of prostate tumor ...

An international study has uncovered a new vulnerability in prostate cancer cells that could help improve treatment for one ...

A UCLA study shows that a new treatment combining a radioactive drug with radiation therapy could help delay hormone therapy ...

Former President Joe Biden is undergoing a five-week radiation regimen as part of his treatment for prostate cancer, his ...

A new study led by University of Manchester scientists has identified genetic variants that make some patients more sensitive ...

Getty ImagesA major international study has uncovered a new vulnerability in prostate cancer cells that could help improve ...

Former President Joe Biden is now receiving radiation therapy for his prostate cancer, a spokesperson for the former president confirmed to ABC News.